References
- Brodeur GM. Neuroblastoma: biological insights into a clinical enigma.
Nat Rev Cancer. 2003 Mar;3(3):203-16. doi: 10.1038/nrc1014. PMID:
12612655.
- Johnsen JI, Dyberg C, Wickström M. Neuroblastoma-A Neural Crest
Derived Embryonal Malignancy. Front Mol Neurosci. 2019 Jan 29;12:9.
doi: 10.3389/fnmol.2019.00009. PMID: 30760980; PMCID: PMC6361784.
- Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K,
Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon
T, Cohn SL, Pearson AD; INRG Task Force. The International
Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force
report. J Clin Oncol. 2009 Jan 10;27(2):298-303. doi:
10.1200/JCO.2008.16.6876. Epub 2008 Dec 1. PMID: 19047290; PMCID:
PMC2650389.
- Parodi S, Sorrentino S, Cataldo AD, Tondo A, Fagnani AM, Perri P,
Gigliotti AR, Erminio G, Corrias MV, De Bernardi B. Metastatic
progression in infants diagnosed with stage 4S neuroblastoma. A study
of the Italian Neuroblastoma Registry. Pediatr Blood Cancer. 2021
May;68(5):e28904. doi: 10.1002/pbc.28904. Epub 2021 Jan 18. PMID:
33459514.
- Tolbert VP, Matthay KK. Neuroblastoma: clinical and biological
approach to risk stratification and treatment. Cell Tissue Res. 2018
May;372(2):195-209. doi: 10.1007/s00441-018-2821-2. Epub 2018 Mar 23.
PMID: 29572647; PMCID: PMC5918153.
- Mlakar V, Jurkovic Mlakar S, Lopez G, Maris JM, Ansari M, Gumy-Pause
F. 11q deletion in neuroblastoma: a review of biological and clinical
implications. Mol Cancer. 2017 Jun 29;16(1):114. doi:
10.1186/s12943-017-0686-8. PMID: 28662712; PMCID: PMC5492892.
- Guan J, Hallberg B, Palmer RH. Chromosome Imbalances in
Neuroblastoma-Recent Molecular Insight into Chromosome 1p-deletion,
2p-gain, and 11q-deletion Identifies New Friends and Foes for the
Future. Cancers (Basel). 2021 Nov 24;13(23):5897. doi:
10.3390/cancers13235897. PMID: 34885007; PMCID: PMC8657310.
- Mossé YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF,
Laquaglia MJ, Sennett R, Lynch JE, Perri P, Laureys G, Speleman F, Kim
C, Hou C, Hakonarson H, Torkamani A, Schork NJ, Brodeur GM, Tonini GP,
Rappaport E, Devoto M, Maris JM. Identification of ALK as a major
familial neuroblastoma predisposition gene. Nature. 2008 Oct
16;455(7215):930-5. doi: 10.1038/nature07261. Epub 2008 Aug 24. PMID:
18724359; PMCID: PMC2672043.
- Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J,
Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd
Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C,
Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H,
Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K,
Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G,
Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL,
Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R,
Stratton MR, Futreal PA. Mutations of the BRAF gene in human cancer.
Nature. 2002 Jun 27;417(6892):949-54. doi: 10.1038/nature00766. Epub
2002 Jun 9. PMID: 12068308.
- Loo E, Khalili P, Beuhler K, Siddiqi I, Vasef MA. BRAF V600E Mutation
Across Multiple Tumor Types: Correlation Between DNA-based Sequencing
and Mutation-specific Immunohistochemistry. Appl Immunohistochem Mol
Morphol. 2018 Nov/Dec;26(10):709-713. doi:
10.1097/PAI.0000000000000516. PMID: 29271794.
- Miao J, Kusafuka T, Fukuzawa M. Hotspot mutations of BRAF gene are not
associated with pediatric solid neoplasms. Oncol Rep. 2004
Dec;12(6):1269-72. PMID: 15547749.
- Shukla N, Ameur N, Yilmaz I, Nafa K, Lau CY, Marchetti A, Borsu L,
Barr FG, Ladanyi M. Oncogene mutation profiling of pediatric solid
tumors reveals significant subsets of embryonal rhabdomyosarcoma and
neuroblastoma with mutated genes in growth signaling pathways. Clin
Cancer Res. 2012 Feb 1;18(3):748-57. doi:
10.1158/1078-0432.CCR-11-2056. Epub 2011 Dec 5. PMID: 22142829; PMCID:
PMC3271129.
- Zaman A, Wu W, Bivona TG. Targeting Oncogenic BRAF: Past, Present, and
Future. Cancers (Basel). 2019 Aug 16;11(8):1197. doi:
10.3390/cancers11081197. PMID: 31426419; PMCID: PMC6721448.
- Shahid S, Kushner BH, Modak S, Basu EM, Rubin EM, Gundem G,
Papaemmanuil E, Roberts SS. Association of BRAF V600E mutations with
vasoactive intestinal peptide syndrome in MYCN-amplified
neuroblastoma. Pediatr Blood Cancer. 2021 Oct;68(10):e29265. doi:
10.1002/pbc.29265. Epub 2021 Jul 31. PMID: 34331515.